U.S. flag

An official website of the United States government

NC_000023.10:g.71800926_(71804153_71812953)del AND Glycogen phosphorylase kinase deficiency

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 15, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003493329.1

Allele description [Variation Report for NC_000023.10:g.71800926_(71804153_71812953)del]

NC_000023.10:g.71800926_(71804153_71812953)del

Gene:
PHKA1:phosphorylase kinase regulatory subunit alpha 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Preferred name:
NC_000023.10:g.71800926_(71804153_71812953)del
HGVS:
NC_000023.10:g.71800926_(71804153_71812953)del

Condition(s)

Name:
Glycogen phosphorylase kinase deficiency
Synonyms:
Glycogen Storage Disease Type IX
Identifiers:
MedGen: C0268147

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004241128Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Dec 15, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004241128.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The variant involves the deletion of exons 30-31 and a part of exon 32 (i.e. the last exon) in the PHKA1 gene. As it encompasses the last exons, it is predicted to escape nonsense mediated decay (NMD). A presumed nomenclature of c.(3243+1_3244-1)_3598del has been designated for the purposes of this classification. This variant is expected to result in a large deletion change in the PHKA1 gene, removing part of the C-terminal domain (IPR045583) of the encoded protein. The variant was absent in 16120 control chromosomes in the gnomAD database (Structural Variants v2.1 dataset). To our knowledge, no occurrence of c.(3243+1_3244-1)_3598del in individuals affected with Glycogen Phosphorylase Kinase Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. However, multiple variants have been reported in the deleted region in affected individuals (HGMD), which might indicate a functional importance for the deleted protein region. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 14, 2024